Actively Recruiting
Phase II Study of 3-Dose Prostate Stereotactic Body Radiotherapy Using RayPilot HypoCath Image Guidance for Men with Low or Intermediate Risk Prostate Cancer
Led by NHS Lothian · Updated on 2026-01-12
100
Participants Needed
1
Research Sites
52 weeks
Total Duration
AI-Summary
What This Trial Is About
This trial focuses on men with localized early prostate cancer, specifically those with low or favorable intermediate risk according to NCCN criteria. Researchers are evaluating whether reducing the number of curative radiotherapy doses from 5 to 3 can maintain or lower side effects compared to the standard 5-dose treatment used in previous studies. The study uses a Phase II, single-arm design and employs the RayPilot HypoCath tumour tracking system to improve the accuracy of treatment delivery. The treatment involves delivering 3 fractions of prostate Stereotactic Body Radiotherapy SBRT on three consecutive days. The RayPilot HypoCath system, a device placed in the urinary catheter, continuously tracks prostate position during radiotherapy and pauses treatment if the prostate shifts, ensuring precise targeting. The study includes a planning phase with MRI and CT scans using rectal suppositories and bladder filling protocols to optimize imaging and treatment accuracy. Participants will undergo baseline assessments including blood tests and quality of life questionnaires before treatment. During the 3-day treatment period, the catheter with the tracking system is used, and treatment is carefully monitored. Follow-up visits occur frequently for two years post-treatment to track side effects using standard toxicity grading systems and patient-reported outcome measures. The study aims to assess both acute and late side effects and quality of life over this period.
CONDITIONS
Brief Title
The PRECISION Study: 3 Fractions of Prostate SBRT and RayPilot HypoCath Image Guidance
Research Team
R
Richard Allan
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here